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ABSTRACT
Introduction: Viral hepatitis comprises a group of viruses characterized by high global 
prevalence and hepatic tropism. Its epidemiology is extremely variable throughout the 
world, and South America is an endemic place. A better understanding of the regional 
reality is fundamental for proposing new public health measures.
Methods: We conducted an aggregate temporal study of the Viral Hepatitis Database 
of the Ministry of Health of the state of Rio Grande do Sul (RS), with an epidemiological 
profile of the reactive results of HBsAg and Anti-HCV tests, together with data on 
mortality from acute Hepatitis B and chronic viral hepatitis from the respective Health 
Macro-Regions from 2007 to 2015.
Results: The incidence of new cases of hepatitis B in RS during the analyzed period was 
11 (95% CI, 9.7-12.1) cases per 100,000 inhabitants. Meanwhile, the Northern region of 
the state, represented by the municipality of Passo Fundo, had 32.7 (95% CI, 28.3-37) 
and 22.8 (95% CI, 19.5-26) new cases of hepatitis B per 100,000 inhabitants for men 
and women, respectively. The incidence of new cases of hepatitis C in the State of 
Rio Grande do Sul was 29.2 (95% CI, 24.5-34.9 in 100,000 inhabitants).
Conclusion: Viral hepatitis remains an important pathology in the context of Rio 
Grande do Sul and its Macro-Regions.
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Viral hepatitis is a set of viruses with primary capacity to infect the 
liver parenchyma leading to physiological dysfunctions and/or inducing an 
inflammatory process, with the possibility of clinical repercussions. Existing 
subtypes include hepatitis A, B, C, D, and E, which currently account for 
90 percent of all infections. However, the main subtypes in the Brazilian 
context are hepatitis A, B and C1-3.
Each virus has its peculiarities, such as etiological agent and form of 
transmission. While viruses A and E are transmitted by the fecal-oral route, 
subtypes B, C and D are spread parenterally. However, the major common 
point of these viral infections is liver involvement through hepatotropism2,4-6.
These viruses are of a great importance in public health, and are associated 
with several conditions of morbidity and mortality, such as acute inflammatory 
conditions of the liver or chronic processes. Chronic infection can lead to the 
development of cirrhosis, ascites, esophageal varices and metabolic changes 
that can culminate in encephalopathy. The development of hepatocarcinomas, 
a condition closely related to chronic lesions in the liver, is associated with 
high mortality in this population due to late diagnosis and low physiological 
reserve of these patients4,5,7,8.
The main representatives of chronic viral hepatitis are hepatitis 
B and C, of which hepatitis C infection is one of the most common chronic 
liver diseases, accounting for most organ transplants in the United States. 
Approximately 5 to 30% develop cirrhosis over a period of about 25 years 
among those who suffer from HCV infection3,9,10.
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Hepatitis A is the most common cause of acute 
hepatitis in the world. Considered as benign pathology, 
there are cases of acute and severe manifestations 
that culminate in acute liver failure or fulminant 
hepatitis2,11-13.
Hepatitis B can lead to acute and chronic clinical 
features. The clinical course of a patient on first contact 
with B virus depends largely on their age. Vertical 
transmission is associated with high chronification 
rates, close to 95%, while newly infected adult patients 
have a low chronification rate, associated with only 
5%. Viral markers in a hepatitis B infection are HBsAg, 
Anti-HBc and the presence of viral DNA8,14.
When analyzing the epidemiology, it is noticeable 
that the pattern is endemic in certain regions of the 
world15. Brazil represents an intermediate prevalence 
site for both hepatitis B and C. However, it is worth 
mentioning that the diagnostic rates are extremely 
high in the South region, being three times higher 
than the national average1,16,17.
Epidemiological studies are important because 
they allow the understanding of how the pattern of 
the diseases affects the population, enabling the 
development of actions of control and cure. It is from 
the data obtained through this type of research that 
better allocations of resources can be made, such 
as public policies aimed at reducing the transmission 
of viruses or aimed at early diagnosis, for example. 
In this sense, the present study aimed to analyze data 
from the state of Rio Grande do Sul regarding the 
epidemiology of hepatitis in its Health Macro-Regions. 
An individual study of each of these regions makes 
it possible to know more about the regional setting, 
providing theoretical information for specific actions 
in each region.
METHODS
The present analysis was a descriptive and 
temporal aggregate epidemiological study related to 
the period between 2007 and 2015, with information 
from the Brazilian Ministry of Health. The data was 
obtained from the Information System of Notifiable 
Diseases (SINAN) and the Mortality Information 
System (SIM) databases. SINAN is a system in 
which the information about compulsory notification 
diseases are released and includes every state of 
Brazil and its subdivisions. Similarly, SIM is a system 
that collects data on the mortality of various diseases 
around the country. Both systems can be accessed on 
the Department of computer science of the Sistema 
Brazilian public Unified Health System18 de Saúde 
website (DATASUS) and contains information on 
public and private health systems. The demographic 
data was collected from the Brazilian Institute of 
Geography and Statistics19 (IBGE).
The study population consisted on all population 
of Rio Grande do Sul with positive results from 
HBsAg and Anti-HCV reagents and cases of acute 
hepatitis B and chronic viral hepatitis mortalities 
that were diagnosed and recorded, represented 
by the SINAN and SIM systems. Data were 
analyzed and separated according to the age range 
(0-19, 20-39, 40-59, 60-79 and 80 years or more), 
sex (female and male), health macro-regions of the 
State of Rio Grande do Sul (North, Mountainous 
region, Missionary, Metropolitan, South, Midwest and 
Valleys) and absolute population of each subcategory.
The statistical study was done with the program 
GraphPad Prism version 6 and Microsoft Office Excel 
2016 (United States). Statistical comparisons between 
the years and populations were made by Student’s t 
test for the parametric variables and Mann- Whitney 
for the non-parametric variables. The data was also 
treated in descriptive ways. The results were presented 
through graphs and tables for better interpretation 
and exposure of the results. The significant p-values 
of each analysis were defined as being less than or 
equal to 0.05 and the confidence interval adopted 
for the study was 95% (95% CI).
RESULTS
During the years 2007 to 2015, there were 
10,876 and 29,056 new cases of reagent exams 
for HBsAg and Anti-HCV in the state, respectively. 
In the evaluation of crude mortality the amount of 
deaths were 2,755 from chronic viral hepatitis and 
152 from acute hepatitis B.
Diagnostic rates of viral hepatitis B (table 1) in 
Rio Grande do Sul were 12 (95% CI,10.8-14) cases 
for men and 9.5 (95% CI, 8.6-10.4) for women in 
every 100,000 population people over the assessed 
period. The Northern region, whose largest city and 
regulatory center is Passo Fundo, had 32.7 (95% 
CI, 28.3-37) and 22.8 (95% CI 19.5-26) new cases 
of hepatitis B per 100,000 inhabitants for men and 
women, respectively. On the other hand, the region that 
presented the lowest incidence was the Southern region, 
represented by Pelotas, with 3.13 (95% CI, 2.24 - 4.02) 
for males and 1.58 (95% CI, 1, 13-2.02) for women, 
as described in Figure 1.
When the diagnostic rates for  viral hepatitis C (table 2) 
were analyzed,  the values  found were 33 (95% CI, 
26.5-39) cases for males and 26 (95% CI, 20.6-31) for 
females in every 100,000 populationinhabitants. While 
the Missionary Macro-Region, represented by Ijuí, 
presented an average of 8.6 (95% CI, 5.4-11.8) for men 
and 6.2 (95% CI, 4-8.3) for women, the Metropolitan 
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Macro-Region had rates of 51.1 (95% CI, 39-63.2) 
for males and 42.3 (95% CI, 32.5-52) for females 
(Figure 2).
The incidence of hepatitis B among women and 
men was significantly different between these groups, 
in which the incidence in men represented 56 percent 
of all cases in the analyzed period (p <0.007). 
This difference was not found in hepatitis C (p> 0.1).
The mortality rates of hepatitis B during the 
years 2007 to 2015 showed a significant fall of 
almost 68 percent, with the rate being between 
0.1-0.2 deaths per 100,000 inhabitants (p <0.036). 
The mortality rate, on the other hand, from chronic 
viral hepatitis was 3.27 (95% CI, 3.1-3.5) for men 
and 2.27 (95% CI, 2.1-2.47) for women, and these 
differences obtained p <0.0001. However, the mortality 
Figure 1: Incidence of positive HBsAg tests per 
100,000 inhabitants by Health Macro-Region in the State 
of Rio Grande do Sul. Source: DataSUS.
Figure 2: Incidence of positive Anti-HCV tests per 
100,000 inhabitants by Health Macro-Region in the State 
of Rio Grande do Sul. Source: DataSUS.
Table 1: Incidence of Hepatitis B in RS and in its Macro-Regions per 100,000 inhabitants.
Region Men Women
Rio Grande do Sul 12.4 (CI 95%, 10.8 - 13.98) 9.52 (CI 95%, 8.63 - 10.4)
Midwest 4.13 (CI 95%, 2.97 - 5.28) 2.8 (CI 95%, 1.99 - 3.59)
Metropolitan 10.41 (CI 95%, 8.65 - 12.17) 8.33 (CI 95%, 7.11 - 9.54)
Missionary 6.72 (CI 95%, 5.39 - 8.05) 7.05 (CI 95%, 6.01 - 8.1)
North 32.7 (CI 95%, 28.3 - 37.1) 22.8 (CI 95%, 19.5 - 26.1)
Saw 22.46 (CI 95%, 19.7 - 25.2) 19.1 (CI 95%, 16.8 - 21.3)
South 3.13 (CI 95%, 2.24 - 4.02) 1.58 (CI 95%, 1.13 - 2.02)
Vouchers 5.63 (CI 95%, 4.23 - 7.03) 5.5 (CI 95%, 4.17 - 6.94)
Table 2: Incidence of hepatitis C in RS and in its Macro-Regions per 100,000 inhabitants.
Region Men Women
Rio Grande do Sul 32.6 (CI 95%, 26.5 - 39.1) 25.7 (CI 95%, 20.5 - 31)
Midwest 25 (CI 95%, 17 - 32) 16.5 (CI 95%, 10.9 - 22)
Metropolitan 51 (CI 95%, 39 - 63.2) 42.3 (CI 95%, 32.5 - 52)
Missionary 8.6 (CI 95%, 5.4 - 11.8) 6.2 (CI 95%, 4 - 8.3)
North 18.5 (CI 95%, 17 - 20) 14.4 (CI 95%, 12.7 - 16.2)
Saw 21.6 (CI 95%, 17.9 - 25.2) 14.1 (CI 95%, 11.8 - 16.4)
South 26.6 (CI 95%, 19.9 - 33.3) 16.7 (CI 95%, 12.2 -21.1)
Vouchers 10.7 (CI 95%, 8.8 - 12.7) 6.9 (CI 95%, 5.3 - 8.5)
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of chronic viral hepatitis did not show a significant 
reduction during the analyzed years.
DISCUSSION
Viral hepatitis is currently a source of great morbidity 
and mortality in society and the ninth leading cause of 
death in the world, accounting for 1.4 million deaths 
a year. Its epidemiology is extremely variable across 
the world and regions like South America and Asia are 
endemic for hepatitis B, while the United States and 
Europe have a prevalence of less than 0.5 percent1,16.
In this context, Brazil presents intermediate prevalence 
for both viral B and C hepatitis. However, regional 
projections have demonstrated a heterogeneous 
profile of B virus distribution in the five regions, in 
which the state of Rio Grande do Sul presented a 
two-fold higher incidence of hepatitis B compared to 
the national average and much higher than the North 
region8,16,17,20.
It is also worth mentioning the economic impact 
that these viruses cause. A study in the United States 
in 2001 evaluated that the impact of the C virus in 
the year 1997 was close to 5.5 billion dollars for its 
economy, mainly due to chronic liver disease and 
hepatocellular carcinoma. However, the present study 
did not analyze the impact of pain and the family cost 
in the treatment of the disease. This suggests that the 
economic and social impact that this disease causes 
should be higher than the present study indicates9,21.
Based on the analyzed information, it was possible 
to identify that the regional profile of viral hepatitis is 
also very heterogeneous. Some of these differences 
are alarming when analyzed individually, but neutralized 
when examined in a joint investigation. As an example, 
the Northern Macro-Region, represented by Passo 
Fundo, presented a statistically significant difference 
almost three times higher than the RS incidence of 
hepatitis B. And it was ten times higher than the result 
found for other regions, such as Pelotas. However, 
the data shows a decrease in the acute hepatitis B 
mortality rate1.
In contrast, the Metropolitan region, represented 
by Porto Alegre, presented the highest incidence of 
new cases of hepatitis during the analyzed period. 
This higher incidence could possibly be due to 
higher rates of injecting drug use - whose use is a 
risk factor9,10,21,22.
The mortality rate of chronic viral hepatitis remains 
a challenge, and the complications - cirrhosis and 
death - caused by chronicity of viral hepatitis tend to 
increase in subsequent years. Despite presenting a 
fall in their incidence rate, we reiterate this assertion 
since they did not have significant change during the 
analyzed period23.
Another important point indicated by the research 
is the high percentage of involvement among the 
age groups of young adults, with the most affected 
groups being those of 20-39 and 40-59 years for 
hepatitis B and among 40-59 and 60-79 years for 
hepatitis C. Government actions should be structured 
in vaccination campaigns against hepatitis B aiming 
greater coverage, because access is already available 
to the entire population regardless of age, according 
to Ordinance n. 1,533 of August 18, 201623.
According to a paper released by the Government 
of Rio Grande do Sul about a research made between 
the years 1999 and 2009, the rates of viral hepatitis 
B and C in 2009 were 9.66 and 22.44 for each 
100,000 inhabitants, respectively. The most common 
age of impairment was from 30 to 59 yeas of age in 
hepatitis B and 40 to 69 in hepatitis C24. This shows 
that the incidence rate is growing through the years 
for both viruses and, fortunately, the age of diagnosis 
for the B virus is decreasing. Probably, this decrease 
in the age of diagnosis occurred because of better 
health policies, which encourage early diagnosis. 
In addition, for both the incidence of hepatitis B and C, 
women had a diagnosis earlier than men. This fact 
can be explained by prenatal screening programs6,14,25.
However, a difficulty imposed for this research refers 
to underreporting data for the Ministry of Health’s Viral 
Hepatitis database. Therefore, the data presented in 
this study tends to be even greater, which makes these 
diseases even more relevant to the regional context1.
The wide variation of results obtained within the state 
of Rio Grande do Sul is noteworthy. This diversity is due 
to several social aspects, risk factors, and notification. 
Nonetheless, more regionalized epidemiological studies 
are fundamental, since they analyze smaller contexts 
showing patterns of incidence that are hidden when 
only the state average is analyzed.
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